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Objective: The main aim of this case report was to present the method of diagnosis, management, and
the 12-year-follow-up of a patient diagnosed with primary uterine lymphangioleiomyomatosis (LAM).
Case Report: A 47-year-old womanwas admitted to the Department of Thoracosurgery due to pulmonary
lesions suspected to be metastatic. The potential primary site of the neoplasm was not identiﬁed by
previous imaging studies and specialist counseling. The patient had a history of total abdominal hys-
terectomy without ovaries due to a uterine tumor recognized as cellular leiomyoma and left salpingo-
oophorectomy due to a solid ovarian tumor also recognized as leiomyoma. She had previously under-
gone the removal of a left kidney angiomyolipoma. After histopathological examination of the pulmonary
lesions and repeated evaluation of the ovarian and uterine tumors, the diagnosis of primary uterine LAM
with metastases to the ovary and the lungs was established. Although new metastatic lesions occurred,
the patient remained in good condition during the 12-year-follow-up.
Conclusion: The history of our patient and review of the literature suggest that although uterine LAM
presents malignant features (i.e., metastasis), the disease is long lasting and the patient can be in good
condition for a number of years.
Copyright © 2015, Taiwan Association of Obstetrics & Gynecology. Published by Elsevier Taiwan LLC. All
rights reserved.Introduction
Lymphangioleiomyomatosis (LAM) is a rare disease character-
ized by the proliferation of abnormal smooth muscle cells. The
disease usually affects women of reproductive age. LAM may be
sporadic or associated with the tuberous sclerosis complex (TSC),
which is an autosomal dominant, multisystem condition charac-
terized by the development of hamartomas and neoplasms at
various body sites, especially the skin, central nervous system, and
kidney. Mental retardation and epilepsy are also frequent in pa-
tients with TSC [1].
The exact etiology of LAM is currently unknown, despite recent
progress in understanding its pathology [2,3]. LAM occursmainly in
the interstitium of the lungs, however, cases of extrapulmonary
LAM have also been reported. LAM has been detected in several
body regions, including the retroperitoneum, mesentery, ureter,urgery, Poznan University of
land.
bstetrics & Gynecology. Publishedbiliary tract, liver, ovary, adrenal gland, and inguinal or supra-
clavicular lymph nodes [4e6]. We present a rare case of uterine
LAM with malignant course of the disease.Case Report
A 47-year-old woman was admitted to the Department of
Thoracosurgery of Wielkopolska Center of Pulmonology and
Thoracosurgery (Poznan, Poland) in January 2010 for a consultation
regarding lung lesions resembling distant metastases. The lesions
in the lungs were diagnosed in November 2008 during a routine
chest X-ray examination. The patient had previously received
counseling by a surgeon and internist. Previous imaging studies
had failed to recognize the site of origin of the lung metastases. On
admission to the Department of Thoracosurgery, the patient was in
good condition without any clinical symptoms.
The patient had a history of total abdominal hysterectomy
without ovaries because a uterine tumor was recognized as a
cellular leiomyoma in 2001. In November 2008, she had left
salpingo-oophorectomy due to a solid ovarian tumor. The tumorby Elsevier Taiwan LLC. All rights reserved.
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ﬁrst histopathological examination. Immunohistochemical results
were positive for desmin, vimentin, and smooth muscle actin, and
negative for CD1, inhibin, cytokeratin AE1/AE3, S100 protein, and
CD34. The expression of CD31 was weak. The expression of Ki67
was found in 3% of the cell nucleus. Preoperative serum CA125 level
was 60.3 IU/mL. In December 2009, she underwent a third lapa-
rotomy due to a left renal tumor. She had partial nephrectomy, and
the ﬁnal histopathological examination revealed renal
angiomyolipoma.
We performed an X-ray computed tomography (CT) examina-
tion of the chest, which revealedmetastatic lesions, mainly in the III
and VI segments of the right lung and VI and X segments of the left
lung, without ﬂuorodeoxyglucose uptake on positron emission
tomography. Several emphysematous bullae and enlargement of
lymph nodes of the pulmonary hilumwere also visualized. We then
decided to perform video-assisted thoracoscopy with wedge tumor
resection of the right lung. The diagnosis of benign metastasizing
leiomyoma was made following histopathological examination
with the revision of the uterine and ovarian tissue samples.Figure 1. (A) Primary uterine lymphangioleiomyomatosis (LAM). (B) Primary uterine LA
metastasis of the ovary. (D) LAMmetastasis to the ovary with a positive reaction for human m
ﬁrst video-assisted thoracoscopy wedge resection. The photograph presents LAM lesions wit
of LAM metastasis of lungs). LAM lesions resemble uterine and ovarian tumors. All imagesTwo months later, the patient was admitted to the hospital due
to dyspnea with suspected disease progression. An increased
diameter of the lesion in the left lung was detected by CT scans.
Thoracotomy and left lung laser wedge resection was performed in
June 2010. Subsequent histopathological examination with review
of the uterine, ovarian, and renal lesions revealed primary uterine
LAM with metastases to the ovary and lungs. Final diagnosis was
established after immunohistochemical analyses, which revealed
the expression of human melanoma black protein 45 (HMB45) in
the ovarian tumor and lung lesions. There was no possibility for
conducting immunohistochemical analyses on the uterine tumor
samples because the samples were utilized after 10 years of storage.
Experimental tamoxifen therapy was initiated due to intoler-
ance of gestagens and disease progression. However, after 5months
of stabilization, new metastatic lesions were found in the right
lung. We then stopped tamoxifen therapy, and performed right
thoracotomy with wedge laser lung resection and enlarged lymph
node excision. After few months of stabilization, a tumor of
68 mm  44 mm  52 mm in size in the retropubic area was
visualized by CT examination. The tumor was excised in MarchM. The photograph shows penetration of LAM cells into the myometrium. (C) LAM
elanoma black protein 45 (HMB45). (E) LAM metastasis of the lungs obtained from the
hin lung tissue. (F) LAM metastasis of the lungs from right thoracotomy (third resection
, magniﬁcation 50.
Table 1
Clinical characterization, and immunohistochemical and imaging ﬁndings in patients diagnosed with uterine lymphangioleiomyomatosis.
Study Clinical manifestation of
uterine involvement
Age (y) Stigmata
of TSC
Histopathology LAM of
the lungs
Evidence of malignant course Imaging ﬁndings CA125
(IU/mL)
Han et al [10] Prolonged vaginal bleeding 46 NA Smooth muscle actin (þ),
HMB45 (þ)
Absent Metastases to iliac and paraaortic
lymph nodes
TVU: hypervascular tumor
(5.57 cm 2.91 cm) between the uterus
and right ovary.
MRI: tumor (4.0 cm  5.0 cm  4.0 cm)
situated at right posterior of the uterus,
near to and below right ovary. Low
signal on T1W1 and intermediate signal
on T2W1
26.7
Kim et al [11] Anemia, abdominal distension,
menometrorrhagia,
dysmenorrhea
29 Present Smooth muscle actin (þ),
HMB45 (þ)
Present Involvement of both adnexa, pelvic
side walls, and omentum
CT: multiple, large, lobulated, thick-
walled cystic masses involving uterus
and entire pelvic cavity. Hemorrhagic
component within the cysts, without
solid components and calciﬁcations.
MRI: huge, irregularly shaped, cystic
masses involving uterus and
parauterine pelvic cavity. T1:
Hyperintense masses, hematoma
within uterine cavity. T2:
heterogeneously hypointense and
hyperintense, intralesional
hemorrhage. Contrast-enhanced MRI -
no enhancing solid parts
204.01
Torres et al [3] Abdominal distension,
progressive renal insufﬁciency
33 Present Proliferating spindle cells. Smooth
muscle actin (þ), desmin (þ),
vimentin (þ), HMB45 (þ), PCNA
(þ), ER (þ), PR (þ), epithelial
membrane antigen (), S-100 (),
CD57()
Present At diagnosis: concurrent LAM
involvement of the uterus,
perinephric lymph node, and
perirenal cyst
USG and MRI: renal, peripelvic and
perirenal cysts occupying abdomen and
pelvis. Hemorrhagic cyst of the left
adnexa
NA
Torres et al [3] Progressive abdominal
distension 20 y after
hysterectomy due to
menometrorrhagia, LAM
involvement of the uterus.
38 Present Proliferating spindle cells. Smooth
muscle actin (þ), desmin (þ),
vimentin (þ), HMB45 (þ), PCNA
(þ), ER (þ), PR (þ), epithelial
membrane antigen (), S-100 (),
CD57(þ)
Present LAM of the abdomen 20 y after LAM
involvement of the uterus
CT: enlarged kidney by diffuse
angiomyolipomatous inﬁltration
NA
Torres et al [2] 3 y of episodic right pelvic pain 29 Present Proliferating spindle cells. Smooth
muscle actin (þ), desmin (þ),
vimentin (þ), HMB45 (þ), PCNA
(þ), ER (þ), PR (þ), epithelial
membrane antigen (), S-100 (),
CD57 ()
Present At time of diagnosis: LAM of the
uterus coexisting with cystic LAM
lesion in the right pelvic sidewall
USG, CT, MRI: partial cystic mass
(5 cm  3 cm  4 cm) in the right pelvic
sidewall, peritoneal free ﬂuid
NA
Longacre et al [12] Abdominal pain,
menometrorrhagia, anemia
49 Present Smooth muscle actin (þ), desmin
(þ), HMB45 (þ)
Present LAM involvement of the right
fallopian tube, left, and right pelvic
lymph nodes
CT: large uterine mass consistent with a
ﬁbroid, peritoneal free ﬂuid, suspicion
of metastatic implant in the liver
NA
Gyure et al [8] Incidental ﬁnding, signs of
primary disease e ovarian
carcinoma
29 Present Microscopic ﬁnding. Numerous
nodules of LAM. Focal area,
sarcomatous transformation of the
LAM cells. HMB45 (þ), smooth
muscle actin (þ), desmin (þ)
Present LAM involvement of the pelvic and
paraaortic lymph nodes
CT: enlarged retroperitoneal lymph
nodes. Microscopic lesions in the uterus
NA
Gyure et al [8] Incidental ﬁnding, without
signs
33 Present Microscopic ﬁnding. Multiple, small
LAM lesions within myometrium.
No areas of necrosis, atypia, or
mitotic activity. HMB45 (þ),
smooth muscle actin (þ), desmin
(þ)
NA Coexisting retroperitoneal
lymphangioma
CT: cystic uterine adnexal mass
separated from ovary (retroperitoneal
lymphangioma)
NA
(continued on next page)
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conﬁrmed by histopathological examination. A right salpingo-
oophorectomy was performed during the laparotomy. Currently
(i.e., 12 years after the primary diagnosis), the patient is in a stable
and good condition. The patient was determined to be disease-free
during the last CT examination.
Genetic counseling was performed due to the presence of the
renal angiomyolipoma, LAM, and a history of seizures. However, a
deﬁnite diagnosis of the TSC was not established because of normal
brain structure in the magnetic resonance examination. There were
no other major or minor signs of the TSC. The patient was also
examined by a cardiologist and ophthalmologist, and no signs of
TSC were found.
Discussion
To the best of our knowledge, our report is the 10th report of
histopathologically conﬁrmed uterine LAM presented in the liter-
ature. According to the reviewed cases, uterine LAM mainly affects
women of childbearing age (i.e., 29e49 years). The disease is
symptomatic in most cases; however, the symptoms are not spec-
iﬁed. Frequent abnormal uterine bleeding and abdominal pain are
present in uterine LAM patients. Classical stigmata of the TSC were
found in all cases, except the case reported by Lack et al [7] and our
case.
Although LAM is considered to be histologically benign, this
report and previous literature suggest a malignant presentation of
LAM. Recent genetic studies have suggested that LAM, especially
the lung manifestation, is caused by an unusual mechanism of
benign cell metastases [8,9]. Furthermore, we were able to provide
evidence of inﬁltrating growth of LAM lesions, which indicates
malignant characterization of the disease (Figure 1).
All but one case of uterine LAM had lung involvement, whether
histopathologically conﬁrmed or clinically suspected [10]. In the
case of our patient, we did not conduct a radiological examination
of the lungs before the ﬁrst surgery because the uterine tumor was
initially recognized as a cellular leiomyoma.
Metastases to regional lymph nodes were identiﬁed in the
majority of uterine LAM cases. As found in our patient, the uterine
adnexa were involved in two previously described LAM cases
[11,12]. Kim et al [11] reported about the dissemination of LAM
lesions within the pelvic side walls and omentum. In the case re-
ported by Lack et al [7], proliferating LAM cells were found within
the liver parenchyma and lymphatic vessels of the adrenal gland. In
our case, there was no evidence of lymph node involvement during
CT imaging. Moreover, intraoperative examination of a frozen
section of the ovarian tumor did not indicate malignant disease.
Therefore, the lymph nodes were not resected.
There is a lack of information regarding long-term follow up of
patients with uterine LAM. Han et al [10] and Lack et al [7] reported
6 months of follow up after initial surgery without evidence of
recurrence, and Gyure et al [8] reported 8 months of follow up. We
presented 12 years of patient follow up. We were able to show that
although uterine LAM is characterized by multiple recurrences and
dissemination within distant parts of the body (i.e., lungs), the
disease progresses slowly and is not debilitating, because the pa-
tients remain in good condition without evidence of cachexia
during the years of follow up. Characterization of all cases of uterine
LAM, including imaging ﬁndings and CA125 levels, are summarized
in Table 1.
The treatment of LAM is a challenge for clinicians due to the lack
of a clinically proven therapy. Currently, the efforts for treating LAM
are mainly focused on the inhibition of estrogen action using ges-
tagens. However, this therapy is only rarely effective and may even
worsen the prognosis in some cases [13]. Although tamoxifen
D. Szpurek et al. / Taiwanese Journal of Obstetrics & Gynecology 54 (2015) 603e607 607therapy is not recommended [14], we started the therapy due to a
signiﬁcant intolerance of gestagens by our patient. Unfortunately,
the therapy was not successful. Among the new strategies for LAM
treatment, the administration of sirolimus seems to be successful
[15]. In the case of our patient, hormonal treatment was unsuc-
cessful; however, some beneﬁts were obtained from repeated re-
sections of lung lesions.
To summarize, the history of our patient and review of the
literature suggest that primary uterine LAM has a malignant pre-
sentation with a tendency for metastasis and recurrence. The dis-
ease is frequently associated with LAM involvement of the lungs
and regional lymph node metastases. However, despite the lack of
an effective treatment, the disease is long lasting and the patient
may stay in a good condition for many years.
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